Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by IDEA Pharma and SAI MedPartners. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IDEA Pharma and SAI MedPartners or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Industrial Revolution of Drug Discovery with Dr. Michael Secora

51:36
 
Share
 

Manage episode 350353215 series 3382232
Content provided by IDEA Pharma and SAI MedPartners. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IDEA Pharma and SAI MedPartners or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Welcome to another incredible episode of the IDEA Collider series with your host Mike Rea. Today the Chief Financial Officer at Recursion, Dr. Michael Secora, joins us on the show as we discuss the industrial revolution of drug discovery. Michael is a scientist and a former equity investor.

In the episode, Michael delves into the reasons behind the incredibly fast growth at Recursion, the company’s mission of decoding biology to radically improve lives, the relatability of data, and how Recursion builds its various data sets for drug discovery. Moreover, he expounds on how Recursion stands out against its competitors in the tech industry, the unique demographics of the Recursion team, and what differentiates Recursion from other AI discovery companies.

Tune in!

During this episode, you will learn about;

[00:23] Introducing today’s episode

[01:29] About Michael Secora and Recursion as it is today

[04:58] Recursion’s Mission on decoding biology to improve lives radically

[08:48] Biotechnology versus BioPharma Companies

[15:00] Relatability of Data

[17:10] Recursion’s data sets & their contents

[22:13] How many terabytes of data are they in executing each experiment

[24:15] How Recursion stands out against competitors in the Tech environment

[26:23] Michael’s approach to humility in the pharmaceutical industry

[28:28] Demographics of the Recursion team

[31:20] Recursion’s Hack Week

[34:51] The difference between AI discovery companies & Recursion

[40:11] A hint of Recursion incredible speed in delivering value proposition

[47:47] Michael’s Book Recommendations

[50:16] How to connect with Michael & Recursion`

Don’t forget to Follow, Rate, Review, Like, and Share!

Mentioned Books

Let’s Connect!

Follow Recursion on;

Follow Michael Secora

More Products

Follow Mike Rea on;

To listen to more amazing podcast episodes: https://podcast.ideapharma.com/

  continue reading

60 episodes

Artwork
iconShare
 
Manage episode 350353215 series 3382232
Content provided by IDEA Pharma and SAI MedPartners. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by IDEA Pharma and SAI MedPartners or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Welcome to another incredible episode of the IDEA Collider series with your host Mike Rea. Today the Chief Financial Officer at Recursion, Dr. Michael Secora, joins us on the show as we discuss the industrial revolution of drug discovery. Michael is a scientist and a former equity investor.

In the episode, Michael delves into the reasons behind the incredibly fast growth at Recursion, the company’s mission of decoding biology to radically improve lives, the relatability of data, and how Recursion builds its various data sets for drug discovery. Moreover, he expounds on how Recursion stands out against its competitors in the tech industry, the unique demographics of the Recursion team, and what differentiates Recursion from other AI discovery companies.

Tune in!

During this episode, you will learn about;

[00:23] Introducing today’s episode

[01:29] About Michael Secora and Recursion as it is today

[04:58] Recursion’s Mission on decoding biology to improve lives radically

[08:48] Biotechnology versus BioPharma Companies

[15:00] Relatability of Data

[17:10] Recursion’s data sets & their contents

[22:13] How many terabytes of data are they in executing each experiment

[24:15] How Recursion stands out against competitors in the Tech environment

[26:23] Michael’s approach to humility in the pharmaceutical industry

[28:28] Demographics of the Recursion team

[31:20] Recursion’s Hack Week

[34:51] The difference between AI discovery companies & Recursion

[40:11] A hint of Recursion incredible speed in delivering value proposition

[47:47] Michael’s Book Recommendations

[50:16] How to connect with Michael & Recursion`

Don’t forget to Follow, Rate, Review, Like, and Share!

Mentioned Books

Let’s Connect!

Follow Recursion on;

Follow Michael Secora

More Products

Follow Mike Rea on;

To listen to more amazing podcast episodes: https://podcast.ideapharma.com/

  continue reading

60 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play